Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ina Rattmann"'
Publikováno v:
Cytotherapy. 14:451-460
Drug-resistance genes have been explored as powerful in vivo selection markers in hematopoietic cell gene therapy, and cytidine deaminase (CDD) represents a particularly attractive candidate given the virtual absence of non-hematopoietic side-effects
Autor:
Ursula R. Sorg, Bertram Opalka, Veronika Kleff, Ina Rattmann, Michael Flasshove, Thomas Moritz, Carsten Ludwig, Anja Feldmann
Publikováno v:
Intervirology. 50:197-203
Objective: Retroviral vectors represent one of the most robust technologies for in vivo expression of heterologous gene sequences and are still the most commonly used vectors in clinical gene therapy trials. The production of high titer retroviral pr
Autor:
Siegfried Seeber, Walter Bardenheuer, Veronika Kleff, Michael Flasshove, Ursula R. Sorg, Ralf A. Hilger, Ina Rattmann, T. Moritz, Annette Brueckner, Bertram Opalka
Publikováno v:
Blood. 108:2965-2971
Hematopoietic stem cell gene transfer of the drug-resistance gene cytidine deaminase (CDD) protecting cells from the cytotoxic cytidine analogs cytarabine and gemcitabine was investigated in a murine transplant model. Following transplantation of CDD
Autor:
Victoria Summey, Carlo M. Croce, David Z. Drew, Lars U.W. Müller, John C. Byrd, Ina Rattmann, Jose A. Cancelas, T. Moritz, Patrick Johnston, Yi Gu, David A. Williams, Abel Sanchez-Aguilera, David M. Lucas
Publikováno v:
Leukemia
RhoH is a hematopoietic-specific, GTPase-deficient member of the Rho GTPase family that functions as a regulator of thymocyte development and T-cell receptor signaling by facilitating localization of zeta-chain-associated protein kinase 70 (ZAP70) to
Autor:
Ina Rattmann, Christopher Poremba, Takuji Suzuki, T. Moritz, Carsten Bury, Ursula R. Sorg, Bertram Opalka, Uta Dirksen, Bruce C. Trapnell, Michael Flasshove, Veronika Kleff, Moran Jerabek-Willemsen
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 16(4)
Pulmonary alveolar proteinosis (PAP) due to deficiency of the common beta-chain (beta(c)) of the interleukin-3 (IL-3)/IL-5/granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors is a rare monogeneic disease characterized by functional in
Publikováno v:
Cell Technology for Cell Products ISBN: 9781402054754
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d0a9f13fb888317848abba2bf610e8c
https://doi.org/10.1007/978-1-4020-5476-1_44
https://doi.org/10.1007/978-1-4020-5476-1_44
Autor:
A Brueckner, Siegfried Seeber, T. Moritz, K Lehmberg, Walter Bardenheuer, Ina Rattmann, Ursula R. Sorg, Michael Flasshove, A. Schneider
Publikováno v:
Leukemia. 19(12)
Overexpression of the detoxifying enzyme cytidine deaminase (CDD) renders normal and leukemic hematopoietic cells resistant to cytarabine (1-beta-D-arabinofuranosylcytosine), and studies on murine cells have suggested transgenic CDD overexpression as
Publikováno v:
GBM Annual Fall meeting M�nster 2004. 2004
Autor:
Moran Jerabek-Willemsen, Elke Grassman, Mi-Ok Kim, T. Moritz, Geoffrey P. Margison, Axel Schambach, Emily Broun, Jürgen Thomale, David A. Williams, Michael D. Milsom, Chad E. Harris, Christopher Baum, Jeff Bailey, Ina Rattmann
Publikováno v:
Blood Cells, Molecules, and Diseases. 40:292-293
Publikováno v:
Blood. 110:339-339
RhoH is a hematopoietic-specific small GTPase which is constitutively active due to lack of intrinsic GTPase activity, suggesting that expression levels of RhoH regulate cellular function. Our lab has previously shown that RhoH in T-cells directly in